Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378

Co-Planar Stereotaxic Atlas of the Human Brain

Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798

Dissociable intrinsic connectivity networks for salience processing and executive control

Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and pharmacology in schizophrenia

Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693

The debate over dopamine’s role in reward: the case for incentive salience

Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024

Endogenous Potentials Generated in the Human Hippocampal Formation and Amygdala by Infrequent Events

Halgren, E., Squires, N. K., Wilson, C. L., Rohrbaugh, J., Babb, T. L., & Crandall, P. H. (1980) · Science · doi:10.1126/science.7434000 · Cited by 778

Reduction in Cerebral Perfusion after Heroin Administration: A Resting State Arterial Spin Labeling Study

Denier, N., Gerber, H., Vogel, M., Klarhöfer, M., Riecher‐Rössler, A., Wiesbeck, G. A., Lang, U. E., Borgwardt, S., & Walter, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071461 · Cited by 30

Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure

Colizzi, M., McGuire, P. K., Giampietro, V., Williams, S., Brammer, M. J., & Bhattacharyya, S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.04.003 · Cited by 28

The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol

Gunasekera, B., Davies, C., Martín‐Santos, R., & Bhattacharyya, S. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.10.007 · Cited by 27

Functional brain connectomes reflect acute and chronic cannabis use

Ramaekers, J. G., Mason, N. L., Toennes, S. W., Theunissen, E. L., & Amico, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-06509-9 · Cited by 27

Cannabinoid–glutamate interactions and neural oscillations: implications for psychosis

Sherif, M. A., Cortes-Briones, J., Ranganathan, M., & Skosnik, P. D. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13800 · Cited by 28

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use

Løberg, E., Nygård, M., Berle, J. Ø., Johnsen, E., Kroken, R. A., Jørgensen, H. A., & Hugdahl, K. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00094 · Cited by 27

Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis

Schoeler, T., Petros, N., Forti, M. D., Klamerus, E., Foglia, E., Murray, R. M., & Bhattacharyya, S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.05.009 · Cited by 26

Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states

Zaytseva, Y., Horáček, J., Hlinka, J., Fajnerová, I., Androvičová, R., Tintěra, J., Salvi, V., Balı́ková, M., Hložek, T., Španiel, F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119849814 · Cited by 25

The Influence of Recreational Substance Use in TMS Research

Turco, C. V., Arsalan, S. O., & Nelson, A. J. (2020) · Brain Sciences · doi:10.3390/brainsci10100751 · Cited by 26

Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

Sadaka, A. H., Ozuna, A. G., Ortiz, R. J., Kulkarni, P., Johnson, C. T., Bradshaw, H. B., Cushing, B. S., Li, A.-L., Hohmann, A. G., & Ferris, C. F. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02891-6 · Cited by 24

Adolescent Marijuana Dependence: The Role of Social Bonds and Social Learning Theory

Hahlbeck, S. M., & Vito, A. G. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.1903122 · Cited by 23

Delayed preattentional functioning in early psychosis patients with cannabis use

Pesa, N., Hermens, D. F., Battisti, R. A., Kaur, M., Hickie, I. B., & Solowij, N. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2676-2 · Cited by 23

Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review

Wilson, R. P., & Bhattacharyya, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115612237 · Cited by 23

Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims

Engeli, B. E., Lachenmeier, D. W., Diel, P. R., Guth, S., Villar-Fernandez, M., Roth, A., Lampen, A., Cartus, A. T., Wätjen, W., Hengstler, J. G., et al. (2025) · Nutrients · doi:10.3390/nu17030489 · Cited by 23

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion

Boggs, D. L., Peckham, A. M., Boggs, A. A., & Ranganathan, M. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.11.277 · Cited by 24

Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?

Greydanus, D. E., Kaplan, G., Baxter, L. E., Patel, D. R., & Feucht, C. L. (2015) · Disease-a-Month · doi:10.1016/j.disamonth.2015.01.004 · Cited by 22

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans

Colizzi, M., Weltens, N., McGuire, P. K., Oudenhove, L. V., & Bhattacharyya, S. (2019) · Brain Sciences · doi:10.3390/brainsci9040093 · Cited by 21

A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis

Cupo, L., Plitman, E., Guma, E., & Chakravarty, M. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01295-w · Cited by 21

Autism and associated disorders: cannabis as a potential therapy

Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 27

Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies

Cooper, Z. D., & Abrams, D. I. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669628 · Cited by 21

Salience attribution and its relationship to cannabis-induced psychotic symptoms

Bloomfield, M., Mouchlianitis, E. D., Morgan, C. J. A., Freeman, T. P., Curran, H. V., Roiser, J. P., & Howes, O. D. (2016) · Psychological Medicine · doi:10.1017/s0033291716002051 · Cited by 21

Cannabis Use, Psychotic Like Experiences and Aberrant Salience in a Sample of Belgian Students

Bernardini, F., Gobbicchi, C., Attademo, L., Puchalski, S., Trezzi, R., Moretti, P., Tortorella, A. A. V., & Loas, G. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000849 · Cited by 22

Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review

Reid, S. W., & Bhattacharyya, S. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112523 · Cited by 20

Early Cannabis Use Is Associated With Severity of Cocaine-Induced Psychosis Among Cocaine Smokers in Martinique, French West Indies

Trape, S., Charles‐Nicolas, A., Jehel, L., & Lacoste, J. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000003 · Cited by 18

Neurocognitive effects of cannabis: Lessons learned from human experimental studies

Colizzi, M., & Bhattacharyya, S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.010 · Cited by 19

Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)

Lo, L. A., Christiansen, A. L., Strickland, J. C., Pistawka, C. A., Eadie, L., Vandrey, R. G., & MacCallum, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01847-w · Cited by 22

Cannabis use‐related working memory deficit mediated by lower left hippocampal volume

Paul, S., & Bhattacharyya, S. (2020) · Addiction Biology · doi:10.1111/adb.12984 · Cited by 17

Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety

Fliegel, D. K., & Lichenstein, S. D. (2022) · Psychiatry Research Communications · doi:10.1016/j.psycom.2022.100074 · Cited by 20

Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects ofδ-9-THC

Bhattacharyya, S., Sainsbury, T. T. J., Allen, P., Nosarti, C., Atakan, Z., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2018) · Psychological Medicine · doi:10.1017/s0033291718000387 · Cited by 17

Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function

Atkinson, D. L., & Abbott, J. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00003-3 · Cited by 16

Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis

Crippa, J. A., Hallak, J. E. C., Abílio, V. C., de Lacerda, A., & Zuardi, A. W. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150909113930 · Cited by 17

Sensorimotor gating, cannabis use and the risk of psychosis

Winton‐Brown, T., Kumari, V., Windler, F., Moscoso, A., Stone, J. M., Kapur, S., & McGuire, P. K. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.017 · Cited by 16

Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex

Kowal, M. A., Hazekamp, A., Colzato, L. S., van Steenbergen, H., & Hommel, B. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00147 · Cited by 16

Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study

Androvičová, R., Horáček, J., Tintěra, J., Hlinka, J., Rydlo, J., Ježová, D., Balı́ková, M., Hložek, T., Miksatkova, P., Kuchař, M., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4601-1 · Cited by 15

Does thinner right entorhinal cortex underlie genetic liability to cannabis use?

Paul, S., & Bhattacharyya, S. (2018) · Psychological Medicine · doi:10.1017/s0033291718000417 · Cited by 15

Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls

van Tricht, M. J., Harmsen, E. C., Koelman, J. H. T. M., Bour, L. J., van Amelsvoort, T., LINSZEN, D. H., de Haan, L., & Nieman, D. H. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2013.03.012 · Cited by 15

Early Effects of Reward Anticipation Are Modulated by Dopaminergic Stimulation

Apitz, T., & Bunzeck, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108886 · Cited by 14

Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder

Kearney-Ramos, T. E., & Haney, M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110290 · Cited by 12

Cannabis-Associated Psychotic-like Experiences Are Mediated by Developmental Changes in the Parahippocampal Gyrus

Yu, T., Jia, T., Zhu, L., Desrivières, S., Macare, C., Bi, Y., Bokde, A. L. W., Quinlan, E. B., Heinz, A., Ittermann, B., et al. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.05.034 · Cited by 15

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review

Bartoli, F., Riboldi, I., Bachi, B., Calabrese, A., Moretti, F., Crocamo, C., & Carrà, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061303 · Cited by 16

Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging

Walter, M., Denier, N., Vogel, M., & Lang, U. E. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805289971 · Cited by 12

High genes: Genetic underpinnings of cannabis use phenotypes

Thorpe, H. H. A., Talhat, M. A., & Khokhar, J. Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110164 · Cited by 12

Is there sufficient evidence that cannabis use is a risk factor for psychosis?

Colizzi, M., & Bhattacharyya, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00016-8 · Cited by 11

The Association Between Cannabinoids and Psychosis

Tikka, S. K., & D’Souza, D. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_14 · Cited by 10

THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults

Cabeen, R. P., Allman, J. M., & Toga, A. W. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa087 · Cited by 13

Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis

Gunasekera, B., Davies, C., Blest-Hopley, G., Veronese, M., Ramsey, N. F., Bossong, M. G., Radua, J., Bhattacharyya, S., Pretzsch, C., McAlonan, G., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104801 · Cited by 10

U-shaped curve of psychosis according to cannabis use: New evidence from a snowball sample

Brañas, A., Barrigón, M. L., Torres, N. G., Garcelán, S. P., Testal, J. F. R., Lahera, G., & Ruíz-Veguilla, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116660712 · Cited by 10

The Endocannabinoid System in Prefrontal Synaptopathies

Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10

The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial

Kirkland, A. E., Browning, B. D., Meredith, L. R., Robertson, E. J., Herring, C., Tomko, R. L., Gray, K. M., & Squeglia, L. M. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02141-z · Cited by 11

Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity

Karunakaran, K. D., Pascale, M. P., Ozana, N. N., Potter, K. W., Pachas, G. N., Evins, A. E., & Gilman, J. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01876-5 · Cited by 9

Genetic dissection of the psychotomimetic effects of cannabinoid exposure

O’Tuathaigh, C. M. P., Gantois, I., & Waddington, J. L. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.002 · Cited by 9

The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions

Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 8

VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects

Xu, B., Xiao, J., Xu, K., Zhang, Q., Chen, D., Zhang, R., Zhang, M., Zhu, H., Niu, J., Zheng, T., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108178 · Cited by 8

Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol.

Davies, C., Bossong, M., Martins, D., Wilson, R., Appiah-Kusi, E., Blest-Hopley, G., Zelaya, F., Allen, P., Brammer, M., Perez, J., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002775 · Cited by 6

Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

Blest‐Hopley, G., Colizzi, M., Prata, D. P., Giampietro, V., Brammer, M. J., McGuire, P. K., & Bhattacharyya, S. (2021) · Brain Sciences · doi:10.3390/brainsci11091240 · Cited by 9

Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man

Bhattacharyya, S., & Sendt, K.-V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00022 · Cited by 9

Cannabis-Induced Psychotic Disorders

Pauselli, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00008-2 · Cited by 8

Effects of the Acute and Chronic Administration of Cannabidiol on Cognition in Humans and Animals: A Systematic Review

Bomfim, A. J. D. L., Zuze, S. M. F., Fabrício, D. D. M., Pessoa, R. M. D. P., Crippa, J. A. S., & Chagas, M. H. N. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0086 · Cited by 7

Do the effects of cannabis on the hippocampus and striatum increase risk for psychosis?

Daniju, Y., Bossong, M. G., Brandt, K. R., & Allen, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.010 · Cited by 7

Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats

Hudson, R., Norris, C., Szkudlarek, H. J., Khan, D., Schmid, S., Rushlow, W. J., & Laviolette, S. R. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06029-w · Cited by 7

Neuroimaging as a Translational Tool in Animal and Human Models of Schizophrenia

Steckler, T., & Salvadore, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00007-x · Cited by 6

Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review

Hurzeler, T. P., Watt, J., Logge, W., Towers, E., Suraev, A. S., Lintzeris, N., Haber, P., & Morley, K. C. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00224-0 · Cited by 7

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

Davies, C., Bossong, M. G., Martins, D., Wilson, R. P., Appiah‐Kusi, E., Blest‐Hopley, G., Allen, P., Zelaya, F. O., Lythgoe, D. J., Brammer, M. J., et al. (2023) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgad022 · Cited by 6

Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials

Köck, P., Badek, A., Meyer, M., Klaassen, A.-L., Walter, M., & Kindler, J. (2024) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-024-00846-5 · Cited by 7

Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients

Alasmari, F. F., Alsanea, S., Alfadda, A. A., Alanazi, I. O., Musambil, M., Masood, A., Alqahtani, F., Fantoukh, O. I., Alasmari, A. F., & Benabdelkamel, H. (2021) · Molecules · doi:10.3390/molecules26175311 · Cited by 5

Standing out: an atypical salience account of creativity

Gross, M. E., & Schooler, J. W. (2024) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2024.04.013 · Cited by 5

The role of aberrant salience in the association between cannabis use frequency and psychotic experiences among racial and ethnic minoritized youth.

Anglin, D. M., Tikhonov, A. A., Tayler, R., & Devylder, J. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.016 · Cited by 5

Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity

Greenwood, L., Broyd, S. J., van Hell, H. H., Todd, J., Jones, A. L., Murray, R. M., Croft, R. J., Michie, P. T., & Solowij, N. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05997-3 · Cited by 4

Cannabis Use, Schizotypy and Kamin Blocking Performance

Dawes, C., Bickerdike, A., O’Neill, C., Pereira, S. C., Waddington, J. L., Moran, P. M., & O’Tuathaigh, C. M. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.633476 · Cited by 3

Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

Lorenzetti, V., McTavish, E., Broyd, S. J., van Hell, H., Thomson, D., Ganella, E. P., Kottaram, A., Beale, C., Martin, J. H., Galettis, P., et al. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0336 · Cited by 5

Clinical Diagnosis and Management of Gradual Onset Cannabis-Induced Psychosis Following the Consumption of Delta-8-Tetrahydrocannabinol

Denton, E. E., Jung, S. S., & Ventura, C. (2024) · Cureus · doi:10.7759/cureus.55464 · Cited by 3

Marijuana Legalization Will Cause Many Problems for Missouri Law Enforcement and Schools.

Evans, D. G. (2019) · PubMed Central · Cited by 3

Qualitative and quantitative aspects of information processing in first psychosis: Latent class analyses in patients, at‐risk subjects, and controls

van Tricht, M. J., Bour, L. J., Koelman, J. H. T. M., Derks, E. M., BRAFF, D. L., Wilde, O. B.-D., Boerée, T., LINSZEN, D. H., de Haan, L., & Nieman, D. H. (2014) · Psychophysiology · doi:10.1111/psyp.12379 · Cited by 3

The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms

Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3

Psychotomimetic and Cognitive Effects of Δ 9 -Tetrahydrocannabinol in Laboratory Settings

Cahill, J. D., Gupta, S., Cortes-Briones, J., Radhakrishnan, R., Sherif, M. A., & D’Souza, D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00004-5 · Cited by 4

Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats

Šíchová, K., Mallarino, B., Janečková, L., Palivec, P., Vágnerová, M., Vejmola, Č., Nikolič, M., Olejníková, L., Mazochová, K., Ryšánek, P., et al. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf041 · Cited by 2

Why things get important: GPCRs in salience processing

Blum, N. K., & Reinscheid, R. K. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117768 · Cited by 2

Alterations of THC and CBD ratios and impact on cognition

Zamberletti, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00007-6 · Cited by 2

Hair concentrations of Δ-9-tetrahydrocannabinol and cannabidiol in cannabis consumers psychiatric patients

Barguil, Y., Chiaradia, L., Southwell, G., & Charlot, J.-Y. (2022) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2022.07.002 · Cited by 1

Cannabis and Psychosis: Correlation, Causality, and Consequences

Basu, D., & Parakh, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00048-x · Cited by 2

Cannabis Compounds: Potential Therapy for Neurological Disease

Babayeva, M., & Loewy, Z. G. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005770 · Cited by 1

Biopolymer (Polyhydroxybutrates) Production from Promising Haloarchaea: Characterization, Optimization with in Vitro Cytotoxic Activity

Neyazi, N. K., Tag, H. M., Elshafey, N., & Hagagy, N. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3258 · Cited by 1

Neuroimaging and Genetics of the Acute and Chronic Effects of Cannabis

Martín‐Santos, R., Crippa, J. A. S., & Bhattacharyya, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00040-5 · Cited by 1

Impact of cannabidiol on brain glucose metabolism of C57Bl /6 male mice previously exposed to cocaine

Spelta, L. E. W., Real, C. C., Bruno, V., Buchpiguel, C. A., Garcia, R. C. T., Torres, L. H., Faria, D. D. P., & Marcourakis, T. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25327 · Cited by 1

Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT

Bhattacharyya, S., Davies, C., Carter, B., McGuire, P. K., Brammer, M. J., Fusar‐Poli, P., Broome, M. R., Watson, S., Pérez, J., & Yung, A. R. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ynfh9826 · Cited by 1

Investigating the Role of the Endocannabinoid System in Early Psychosis

O’Neill, A., & Bhattacharyya, S. (2017) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2017.00009 · Cited by 1

Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders

Deiana, S., & Zamberletti, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00014-8 · Cited by 1

Spatial patterns in functional brain connectomes reflect acute and chronic cannabis usePreprint

Ramaekers, J. G., Mason, N. L., Toennes, S. W., Theunissen, E. L., & Amico, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.08.434333

An insight into the acute effects of cannabidiol on human brain function and their relationship with the brain expression of its molecular targets: a neuroimaging meta-regression analysisPreprint

Gunasekera, B., Davies, C., Blest‐Hopley, G., Wilson, R. P., Busatto, G. F., Crippa, J. A. S., Duran, F., Zuardi, A. W., Veronese, M., Raduà, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1990777/v1

Cannabidiol for people with schizophrenia

Buitrago‐García, D., Sánchez, G., Correa, P. A. S., Baracaldo, S. D. P., Gallego, S. F. G., & Baandrup, L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014602

Psychotropic Effects of Cannabis

Ross, I. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35155-6_6 · Cited by 3

Cannabidiol and Depression: Promise and Challenge in Building an Evidence Base

Moser, A. D., Batt, M. M., Bidwell, L. C., & Kaiser, R. H. (2023) · Adolescent Psychiatry · doi:10.2174/0122106766234102230919064455

Retrospective examination of cannabis vs. other substance misuse: Associations with 30-day readmission and global assessment of functioning in hospitalized patients with serious mental illness

Lane, S. D., Shahani, L., Machado‐Vieira, R., & Soares, J. C. (2024) · Psychiatry Research Communications · doi:10.1016/j.psycom.2024.100167

Overshadowing and salience attribution in relation to cannabis use

Dawes, C., McGreal, S. J., Marwaha, S., Prados, J., Reheis, A., Dumitrescu, A., Waddington, J. L., Moran, P. M., & O’Tuathaigh, C. M. P. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100315

Cannabidiol Therapy for Comorbid Schizophrenia and Addiction: A Guide for Clinical PracticePreprint

Maj, J., & Francis, A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4857098

Deviant sound frequency and time stimuli in auditory oddball tasks reveal persistent aberrant brain activity in patients with psychosis and symptomatic remission

Goena, J., Vidal-Adroher, C., Solis-Barquero, S., Jiménez-Mesa, C., Garcés, M. S., Fernandez, M. A. R., García-Eulate, R., Molero, P., Catalán, A., Alústiza, I., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.01.042

Acute and chronic effects of cannabinoids on human brain: gene-environment interactions related to psychiatric disorders

Batalla, A. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Additional file 1 of Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

Sadaka, A. H., Ozuna, A. G., Ortiz, R. J., Kulkarni, P., Johnson, C. T., Bradshaw, H. B., Cushing, B. S., Li, A.-L., Hohmann, A. G., & Ferris, C. F. (2021) · Figshare · doi:10.6084/m9.figshare.14670466

Cannabis

Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7

Cannabidiol in biomedical research: Potential and challenges

Taha, L., Kammerer, S., Zschoche, N., Brauckhoff, T., Schierack, P., & Rödiger, S. (2026) · Journal of Cellular Biotechnology · doi:10.1177/23523689261464452

Induction of Psychosis by Delta 9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Bhattacharyya, S., Crippa, J. A., Allen, P., Martín‐Santos, R., Borgwardt, S., Fusar‐Poli, P., Rubia, K., Kambeitz, J., O’Carroll, C., Seal, M. L., et al. (2012) · Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) · Cited by 8

ORIGINAL ARTICLE Induction of Psychosis by 9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2015)

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 114

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680

The effects of cannabis use on salience attribution: a systematic review

Wijayendran, S. B., O’Neill, A., & Bhattacharyya, S. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.58 · Cited by 36